title: Transforming growth factor-beta1 regulates steady-state PTH/PTHrP receptor mRNA levels and PTHrP binding in ROS 17/2.8 osteosarcoma cells.
abstract: The effect of transforming growth factor beta1 (TGF-beta1) on the expression of mRNA for the parathyroid hormone receptor and binding of iodinated parathyroid hormone-related protein in ROS 17/2.8 osteosarcoma cells was evaluated. TGF-beta1 stimulated a 2-7-fold increase in steady state mRNA levels for the parathyroid hormone receptor at a maximal dose of 5 ng/ml, with increased levels of expression at 6 h of TGF-beta1-incubation, and peak levels at 8-24 h. Receptor binding studies revealed a significant increase in PTHrP-specific binding with TGF-beta1 doses as low as 0.5 ng/ml and a 55% increase in numbers of receptors with no alteration in binding affinity with 5.0 ng/ml TGF-beta1. Time course studies indicated that receptor binding was increased at 24 h with peak levels reached at 48 h of treatment. PTH-stimulated cAMP levels were significantly increased in ROS 17/2.8 cells treated with TGF-beta1 (0.5 ng/ml) for 48 h. These data indicate that TGF-beta1 upregulates steady-state mRNA, ligand binding and PTH/PTHrP receptor signaling in rat osteosarcoma cells. The effects of TGF-beta1 on bone may be attributed in part to regulation of the PTH/PTHrP receptor at the molecular level.
authors.affiliation: Department of Periodontology / Prevention and Geriatrics, The University of Michigan, Ann Arbor 48109-1078, USA.
authors.forename: L K
authors.initials: LK
authors.lastname: McCauley
authors.forename: C A
authors.initials: CA
authors.lastname: Beecher
authors.forename: M E
authors.initials: ME
authors.lastname: Melton
authors.forename: J R
authors.initials: JR
authors.lastname: Werkmeister
authors.forename: H
authors.initials: H
authors.lastname: Jüppner
authors.forename: A B
authors.initials: AB
authors.lastname: Abou-Samra
authors.forename: G V
authors.initials: GV
authors.lastname: Segre
authors.forename: T J
authors.initials: TJ
authors.lastname: Rosol
mesh_terms: D000818:Animals; D012516:Osteosarcoma / Q000378:metabolism*; D010281:Parathyroid Hormone / Q000378:metabolism; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D051381:Rats; D018016:Receptors, Parathyroid Hormone / Q000096:biosynthesis*; D015398:Signal Transduction / Q000187:drug effects*; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D010281:Parathyroid Hormone; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D012333:RNA, Messenger; D018016:Receptors, Parathyroid Hormone; D016212:Transforming Growth Factor beta